Argenx dealt another blow as Vyvgart Hytrulo fails again

cafead

Administrator
Staff member
  • cafead   Dec 20, 2023 at 09:32: AM
via Shares in Argenx have been taking a bashing this morning after the company announced its new subcutaneous formulation of Vyvgart had missed the mark in another phase 3 trial.

article source